BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Keefe DM, Brealey J, Goland GJ, Cummins AG. Chemotherapy for cancer causes apoptosis that precedes hypoplasia in crypts of the small intestine in humans. Gut. 2000;47:632-637. [PMID: 11034578 DOI: 10.1136/gut.47.5.632] [Cited by in Crossref: 247] [Cited by in F6Publishing: 235] [Article Influence: 11.8] [Reference Citation Analysis]
Number Citing Articles
1 Logan RM. Advances in understanding of toxicities of treatment for head and neck cancer. Oral Oncol. 2009;45:844-848. [PMID: 19467918 DOI: 10.1016/j.oraloncology.2009.03.018] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 2.3] [Reference Citation Analysis]
2 Pontoppidan PL, Shen RL, Petersen BL, Thymann T, Heilmann C, Müller K, Sangild PT. Intestinal response to myeloablative chemotherapy in piglets. Exp Biol Med (Maywood) 2014;239:94-104. [DOI: 10.1177/1535370213509563] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
3 Sonis ST, Elting LS, Keefe D, Peterson DE, Schubert M, Hauer-Jensen M, Bekele BN, Raber-Durlacher J, Donnelly JP, Rubenstein EB. Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients. Cancer. 2004;100:1995-2025. [PMID: 15108222 DOI: 10.1002/cncr.20162] [Cited by in Crossref: 860] [Cited by in F6Publishing: 725] [Article Influence: 50.6] [Reference Citation Analysis]
4 Matsuu-Matsuyama M, Shichijo K, Okaichi K, Nakayama T, Nakashima M, Uemura T, Niino D, Sekine I. Protection by polaprezinc against radiation-induced apoptosis in rat jejunal crypt cells. J Radiat Res 2008;49:341-7. [PMID: 18413982 DOI: 10.1269/jrr.07114] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
5 Zhou R, He D, Xie J, Zhou Q, Zeng H, Li H, Huang L. The Synergistic Effects of Polysaccharides and Ginsenosides From American Ginseng (Panax quinquefolius L.) Ameliorating Cyclophosphamide-Induced Intestinal Immune Disorders and Gut Barrier Dysfunctions Based on Microbiome-Metabolomics Analysis. Front Immunol 2021;12:665901. [PMID: 33968068 DOI: 10.3389/fimmu.2021.665901] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Konya V, Mjösberg J. Innate lymphoid cells in graft-versus-host disease. Am J Transplant 2015;15:2795-801. [PMID: 26228632 DOI: 10.1111/ajt.13394] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 3.7] [Reference Citation Analysis]
7 Rigby RJ, Carr J, Orgel K, King SL, Lund PK, Dekaney CM. Intestinal bacteria are necessary for doxorubicin-induced intestinal damage but not for doxorubicin-induced apoptosis. Gut Microbes 2016;7:414-23. [PMID: 27459363 DOI: 10.1080/19490976.2016.1215806] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 7.6] [Reference Citation Analysis]
8 Al-Dasooqi N, Wardill HR, Gibson RJ. Gastrointestinal mucositis: the role of MMP-tight junction interactions in tissue injury. Pathol Oncol Res 2014;20:485-91. [PMID: 24424533 DOI: 10.1007/s12253-013-9733-y] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
9 Miroddi M, Sterrantino C, Simonelli I, Ciminata G, Phillips RS, Calapai G. Risk of grade 3-4 diarrhea and mucositis in colorectal cancer patients receiving anti-EGFR monoclonal antibodies regimens: A meta-analysis of 18 randomized controlled clinical trials. Critical Reviews in Oncology/Hematology 2015;96:355-71. [DOI: 10.1016/j.critrevonc.2015.06.004] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
10 Thorpe D, Stringer A, Butler R. Chemotherapy-induced mucositis: The role of mucin secretion and regulation, and the enteric nervous system. NeuroToxicology 2013;38:101-5. [DOI: 10.1016/j.neuro.2013.06.007] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
11 Lee CS, Ryan EJ, Doherty GA. Gastro-intestinal toxicity of chemotherapeutics in colorectal cancer: The role of inflammation. World J Gastroenterol 2014; 20(14): 3751-3761 [PMID: 24744571 DOI: 10.3748/wjg.v20.i14.3751] [Cited by in CrossRef: 101] [Cited by in F6Publishing: 93] [Article Influence: 14.4] [Reference Citation Analysis]
12 Logan RM, Gibson RJ, Bowen JM, Stringer AM, Sonis ST, Keefe DM. Characterisation of mucosal changes in the alimentary tract following administration of irinotecan: implications for the pathobiology of mucositis. Cancer Chemother Pharmacol. 2008;62:33-41. [PMID: 17703303 DOI: 10.1007/s00280-007-0570-0] [Cited by in Crossref: 127] [Cited by in F6Publishing: 121] [Article Influence: 9.1] [Reference Citation Analysis]
13 Wei Z, Tan B, Cao S, Liu S, Tan X, Yao Z, Yin N, Li J, Zhang D, Zhou Y. The influence of neoadjuvant chemotherapy on gastric cancer patients' postoperative infectious complications: What is the negative role played by the intestinal barrier dysfunction? Oncotarget 2017;8:43376-88. [PMID: 28118611 DOI: 10.18632/oncotarget.14758] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
14 Rodrigues D, Souza T, Jennen DG, Lemmens L, Kleinjans JC, de Kok TM. Drug-induced gene expression profile changes in relation to intestinal toxicity: State-of-the-art and new approaches. Cancer Treatment Reviews 2019;77:57-66. [DOI: 10.1016/j.ctrv.2019.06.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
15 de Koning BA, van Dieren JM, Lindenbergh-Kortleve DJ, van der Sluis M, Matsumoto T, Yamaguchi K, Einerhand AW, Samsom JN, Pieters R, Nieuwenhuis EE. Contributions of mucosal immune cells to methotrexate-induced mucositis. Int Immunol. 2006;18:941-949. [PMID: 16636014 DOI: 10.1093/intimm/dxl030] [Cited by in Crossref: 57] [Cited by in F6Publishing: 57] [Article Influence: 3.8] [Reference Citation Analysis]
16 Yasuda M, Kato S, Yamanaka N, Iimori M, Matsumoto K, Utsumi D, Kitahara Y, Amagase K, Horie S, Takeuchi K. 5-HT₃ receptor antagonists ameliorate 5-fluorouracil-induced intestinal mucositis by suppression of apoptosis in murine intestinal crypt cells. Br J Pharmacol 2013;168:1388-400. [PMID: 23072534 DOI: 10.1111/bph.12019] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 5.1] [Reference Citation Analysis]
17 Ellis M. Preventing microbial translocation in haematological malignancy: Reviews. British Journal of Haematology 2004;125:282-93. [DOI: 10.1111/j.1365-2141.2004.04903.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.2] [Reference Citation Analysis]
18 Juno RJ, Knott AW, Profitt SA, Jarboe MD, Zhang Y, Erwin CR, Warner BW. Preventing enterocyte apoptosis after massive small bowel resection does not enhance adaptation of the intestinal mucosa. J Pediatr Surg 2004;39:907-11; discussion 907-11. [PMID: 15185223 DOI: 10.1016/j.jpedsurg.2004.02.007] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
19 Stringer AM. Interaction between host cells and microbes in chemotherapy-induced mucositis. Nutrients. 2013;5:1488-1499. [PMID: 23628721 DOI: 10.3390/nu5051488] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 4.3] [Reference Citation Analysis]
20 Marcussen M, Skrubbeltrang C, Bødker JS, Christiansen I, Bøgsted M, Dybkær K, Bergmann OJ, Johnsen HE. A systematic review of molecular responses to cancer therapy in normal human mucosa. Oral Surg Oral Med Oral Pathol Oral Radiol 2017;124:355-66. [PMID: 29042035 DOI: 10.1016/j.oooo.2017.08.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
21 Balzan S, de Almeida Quadros C, de Cleva R, Zilberstein B, Cecconello I. Bacterial translocation: overview of mechanisms and clinical impact. J Gastroenterol Hepatol 2007;22:464-71. [PMID: 17376034 DOI: 10.1111/j.1440-1746.2007.04933.x] [Cited by in Crossref: 212] [Cited by in F6Publishing: 202] [Article Influence: 15.1] [Reference Citation Analysis]
22 Sultani M, Stringer AM, Bowen JM, Gibson RJ. Anti-inflammatory cytokines: important immunoregulatory factors contributing to chemotherapy-induced gastrointestinal mucositis. Chemother Res Pract. 2012;2012:490804. [PMID: 22973511 DOI: 10.1155/2012/490804] [Cited by in Crossref: 31] [Cited by in F6Publishing: 46] [Article Influence: 3.4] [Reference Citation Analysis]
23 Bowen JM, Gibson RJ, Keefe DM, Cummins AG. Cytotoxic chemotherapy upregulates pro-apoptotic Bax and Bak in the small intestine of rats and humans. Pathology 2005;37:56-62. [PMID: 15875735 DOI: 10.1080/00313020400023461] [Cited by in Crossref: 58] [Cited by in F6Publishing: 54] [Article Influence: 3.6] [Reference Citation Analysis]
24 Sun X, Zhang J, Gupta R, Macgibbon AK, Kuhn-Sherlock B, Krissansen GW. Dairy milk fat augments paclitaxel therapy to suppress tumour metastasis in mice, and protects against the side-effects of chemotherapy. Clin Exp Metastasis 2011;28:675-88. [PMID: 21739249 DOI: 10.1007/s10585-011-9400-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
25 Touchefeu Y, Montassier E, Nieman K, Gastinne T, Potel G, Bruley des Varannes S, Le Vacon F, de La Cochetière MF. Systematic review: the role of the gut microbiota in chemotherapy- or radiation-induced gastrointestinal mucositis - current evidence and potential clinical applications. Aliment Pharmacol Ther 2014;40:409-21. [PMID: 25040088 DOI: 10.1111/apt.12878] [Cited by in Crossref: 71] [Cited by in F6Publishing: 117] [Article Influence: 10.1] [Reference Citation Analysis]
26 Bowen JM, Keefe DM. New pathways for alimentary mucositis. J Oncol 2008;2008:907892. [PMID: 19259334 DOI: 10.1155/2008/907892] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
27 Stringer AM, Gibson RJ, Logan RM, Bowen JM, Yeoh AS, Laurence J, Keefe DM. Irinotecan-induced mucositis is associated with changes in intestinal mucins. Cancer Chemother Pharmacol. 2009;64:123-132. [PMID: 18998135 DOI: 10.1007/s00280-008-0855-y] [Cited by in Crossref: 48] [Cited by in F6Publishing: 52] [Article Influence: 3.7] [Reference Citation Analysis]
28 Blijlevens N, Sonis S. Palifermin (recombinant keratinocyte growth factor-1): a pleiotropic growth factor with multiple biological activities in preventing chemotherapy- and radiotherapy-induced mucositis. Ann Oncol. 2007;18:817-826. [PMID: 17030544 DOI: 10.1093/annonc/mdl332] [Cited by in Crossref: 102] [Cited by in F6Publishing: 90] [Article Influence: 6.8] [Reference Citation Analysis]
29 Zuo T, He X, Cao L, Xue C, Tang Q. The dietary polysaccharide from Ommastrephes bartrami prevents chemotherapeutic mucositis by promoting the gene expression of antimicrobial peptides in Paneth cells. Journal of Functional Foods 2015;12:530-9. [DOI: 10.1016/j.jff.2014.12.015] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
30 Lee JM, Chun HJ, Choi HS, Kim ES, Seo YS, Jeen YT, Lee HS, Um SH, Kim CH, Sul D. Selenium Administration Attenuates 5-Flurouracil-Induced Intestinal Mucositis. Nutrition and Cancer 2017;69:616-22. [DOI: 10.1080/01635581.2017.1300289] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
31 Derikx J, Blijlevens N, Donnelly J, Fujii H, Kanda T, van Bijnen A, Heineman E, Buurman W. Loss of enterocyte mass is accompanied by diminished turnover of enterocytes after myeloablative therapy in haematopoietic stem-cell transplant recipients. Annals of Oncology 2009;20:337-42. [DOI: 10.1093/annonc/mdn579] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 3.1] [Reference Citation Analysis]
32 Sylvester CL, Anderson PH, Stringer AM. New therapeutic strategies for combatting gastrointestinal toxicity. Curr Opin Support Palliat Care 2020;14:142-52. [PMID: 32332213 DOI: 10.1097/SPC.0000000000000500] [Reference Citation Analysis]
33 Vanhoecke B, Bateman E, Mayo B, Vanlancker E, Stringer A, Thorpe D, Keefe D. Dark Agouti rat model of chemotherapy-induced mucositis: establishment and current state of the art. Exp Biol Med (Maywood) 2015;240:725-41. [PMID: 25966981 DOI: 10.1177/1535370215581309] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
34 al-Ramadi BK, Ellis M, Pasqualini F, Mantovani A. Selective induction of pentraxin 3, a soluble innate immune pattern recognition receptor, in infectious episodes in patients with haematological malignancy. Clin Immunol 2004;112:221-4. [PMID: 15308113 DOI: 10.1016/j.clim.2004.03.012] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
35 Russo F, Linsalata M, Clemente C, D'Attoma B, Orlando A, Campanella G, Giotta F, Riezzo G. The effects of fluorouracil, epirubicin, and cyclophosphamide (FEC60) on the intestinal barrier function and gut peptides in breast cancer patients: an observational study. BMC Cancer 2013;13:56. [PMID: 23379680 DOI: 10.1186/1471-2407-13-56] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 3.3] [Reference Citation Analysis]
36 Bernal NP, Stehr W, Profitt S, Erwin CR, Warner BW. Combined pharmacotherapy that increases proliferation and decreases apoptosis optimally enhances intestinal adaptation. J Pediatr Surg 2006;41:719-24; discussion 719-24. [PMID: 16567183 DOI: 10.1016/j.jpedsurg.2005.12.016] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
37 Stein A, Voigt W, Jordan K. Chemotherapy-induced diarrhea: pathophysiology, frequency and guideline-based management. Ther Adv Med Oncol. 2010;2:51-63. [PMID: 21789126 DOI: 10.1177/1758834009355164] [Cited by in Crossref: 200] [Cited by in F6Publishing: 175] [Article Influence: 20.0] [Reference Citation Analysis]
38 Kim B, Pena CD, Auguste DT. Targeted Lipid Nanoemulsions Encapsulating Epigenetic Drugs Exhibit Selective Cytotoxicity on CDH1 /FOXM1 + Triple Negative Breast Cancer Cells. Mol Pharmaceutics 2019;16:1813-26. [DOI: 10.1021/acs.molpharmaceut.8b01065] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]
39 Abel E, Ekman T, Warnhammar E, Hultborn R, Jennische E, Lange S. Early Disturbance of Microvascular Function Precedes Chemotherapy-Induced Intestinal Injury. Dig Dis Sci 2005;50:1729-33. [DOI: 10.1007/s10620-005-2926-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
40 Wardill HR, Gibson RJ, Logan RM, Bowen JM. TLR4/PKC-mediated tight junction modulation: a clinical marker of chemotherapy-induced gut toxicity? Int J Cancer 2014;135:2483-92. [PMID: 24310924 DOI: 10.1002/ijc.28656] [Cited by in Crossref: 25] [Cited by in F6Publishing: 16] [Article Influence: 3.6] [Reference Citation Analysis]
41 Sun JZ, Ha XQ, Zhang LM, Wang HB, Wang HW, Duan HF. Attenuated Salmonella typhimurium carrying the hepatocyte growth factor and keratinocyte growth factor genes repairs gastrointestinal mucosal damage caused by chemotherapy. Med Oncol. 2013;30:453. [PMID: 23335069 DOI: 10.1007/s12032-012-0453-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
42 Gibson RJ, Bowen JM, Alvarez E, Finnie J, Keefe DM. Establishment of a single-dose irinotecan model of gastrointestinal mucositis. Chemotherapy. 2007;53:360-369. [PMID: 17713326 DOI: 10.1159/000107458] [Cited by in Crossref: 45] [Cited by in F6Publishing: 36] [Article Influence: 3.2] [Reference Citation Analysis]
43 Zuo T, Cao L, Xue C, Tang Q. Dietary squid ink polysaccharide induces goblet cells to protect small intestine from chemotherapy induced injury. Food Funct 2015;6:981-6. [DOI: 10.1039/c4fo01191k] [Cited by in Crossref: 26] [Cited by in F6Publishing: 7] [Article Influence: 4.3] [Reference Citation Analysis]
44 Kaczmarek A, Brinkman BM, Heyndrickx L, Vandenabeele P, Krysko DV. Severity of doxorubicin-induced small intestinal mucositis is regulated by the TLR-2 and TLR-9 pathways: TLR-2 and TLR-9 in doxorubicin-induced small intestinal mucositis. J Pathol 2012;226:598-608. [DOI: 10.1002/path.3009] [Cited by in Crossref: 70] [Cited by in F6Publishing: 67] [Article Influence: 7.0] [Reference Citation Analysis]
45 Macvittie TJ, Farese AM, Parker GA, Jackson W, Booth C, Tudor GL, Hankey KG, Potten CS. The Gastrointestinal Subsyndrome of the Acute Radiation Syndrome in Rhesus Macaques: A Systematic Review of the Lethal Dose-response Relationship With and Without Medical Management. Health Physics 2019;116:305-38. [DOI: 10.1097/hp.0000000000000903] [Cited by in Crossref: 18] [Cited by in F6Publishing: 6] [Article Influence: 9.0] [Reference Citation Analysis]
46 Sukhotnik I, Geyer T, Pollak Y, Mogilner JG, Coran AG, Berkowitz D. The role of Wnt/β-catenin signaling in enterocyte turnover during methotrexate-induced intestinal mucositis in a rat. PLoS One 2014;9:e110675. [PMID: 25375224 DOI: 10.1371/journal.pone.0110675] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
47 Bernal NP, Stehr W, Coyle R, Erwin CR, Warner BW. Epidermal growth factor receptor signaling regulates Bax and Bcl-w expression and apoptotic responses during intestinal adaptation in mice. Gastroenterology. 2006;130:412-423. [PMID: 16472596 DOI: 10.1053/j.gastro.2005.11.006] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 1.7] [Reference Citation Analysis]
48 Gibson RJ, Bowen JM, Keefe DM. Technological advances in mucositis research: new insights and new issues. Cancer Treat Rev 2008;34:476-82. [PMID: 18358615 DOI: 10.1016/j.ctrv.2008.02.001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
49 Epstein RJ, Leung TWT, Cheung PSY. Panmucositis and chemosensitisation associated with betel quid chewing during dose-dense adjuvant breast cancer chemotherapy. Cancer Chemother Pharmacol 2006;58:835-7. [DOI: 10.1007/s00280-006-0218-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
50 Ypsilantis P, Tentes L, Assimakopoulos SF, Kortsaris A, Scopa CD, Pitiakoudis M, Simopoulos C. Dose related effects of ifosfamide on enterocyte apoptosis in different sites of the rabbit intestine. Toxicology 2004;200:135-43. [DOI: 10.1016/j.tox.2004.03.020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
51 Wang L, Zhai M, Lin B, Cui W, Hull L, Li X, Anderson MN, Smith JT, Umali MV, Jiang S, Kiang JG, Xiao M. PEG-G-CSF and L-Citrulline Combination Therapy for Mitigating Skin Wound Combined Radiation Injury in a Mouse Model. Radiat Res 2021;196:113-27. [PMID: 33914884 DOI: 10.1667/RADE-20-00151.1] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
52 Leibowitz BJ, Yang L, Wei L, Buchanan ME, Rachid M, Parise RA, Beumer JH, Eiseman JL, Schoen RE, Zhang L, Yu J. Targeting p53-dependent stem cell loss for intestinal chemoprotection. Sci Transl Med. 2018;10. [PMID: 29437148 DOI: 10.1126/scitranslmed.aam7610] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 10.0] [Reference Citation Analysis]
53 Southcott E, Tooley KL, Howarth GS, Davidson GP, Butler RN. Yoghurts containing probiotics reduce disruption of the small intestinal barrier in methotrexate-treated rats. Dig Dis Sci 2008;53:1837-41. [PMID: 18427990 DOI: 10.1007/s10620-008-0275-1] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 2.2] [Reference Citation Analysis]
54 Bachour PC, Sonis ST. Predicting mucositis risk associated with cytotoxic cancer treatment regimens: rationale, complexity, and challenges. Curr Opin Support Palliat Care 2018;12:198-210. [PMID: 29547492 DOI: 10.1097/SPC.0000000000000339] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
55 McQuade RM, Stojanovska V, Donald EL, Rahman AA, Campelj DG, Abalo R, Rybalka E, Bornstein JC, Nurgali K. Irinotecan-Induced Gastrointestinal Dysfunction Is Associated with Enteric Neuropathy, but Increased Numbers of Cholinergic Myenteric Neurons. Front Physiol 2017;8:391. [PMID: 28642718 DOI: 10.3389/fphys.2017.00391] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
56 Braga-Neto MB, Warren CA, Oriá RB, Monteiro MS, Maciel AA, Brito GA, Lima AA, Guerrant RL. Alanyl-glutamine and glutamine supplementation improves 5-fluorouracil-induced intestinal epithelium damage in vitro. Dig Dis Sci 2008;53:2687-96. [PMID: 18320312 DOI: 10.1007/s10620-008-0215-0] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
57 Araújo CV, Lazzarotto CR, Aquino CC, Figueiredo IL, Costa TB, Alves LA, Ribeiro RA, Bertolini LR, Lima AA, Brito GA, Oriá RB. Alanyl-glutamine attenuates 5-fluorouracil-induced intestinal mucositis in apolipoprotein E-deficient mice. Braz J Med Biol Res 2015;48:493-501. [PMID: 25945744 DOI: 10.1590/1414-431X20144360] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
58 Lee CS, Ryan EJ, Doherty GA. Gastro-intestinal toxicity of chemotherapeutics in colorectal cancer: the role of inflammation. World J Gastroenterol. 2014;20:3751-3761. [PMID: 24744571 DOI: 10.3748/wjg.v20.il14.3751] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
59 Pontoppidan PE, Shen RL, Cilieborg MS, Jiang P, Kissow H, Petersen BL, Thymann T, Heilmann C, Müller K, Sangild PT. Bovine Colostrum Modulates Myeloablative Chemotherapy-Induced Gut Toxicity in Piglets. J Nutr 2015;145:1472-80. [PMID: 26019247 DOI: 10.3945/jn.114.203430] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
60 Takita H, Darwich AS, Ahmad A, Rostami-Hodjegan A. Application of the Nested Enzyme-Within-Enterocyte (NEWE) Turnover Model for Predicting the Time Course of Pharmacodynamic Effects. CPT Pharmacometrics Syst Pharmacol 2020;9:617-27. [PMID: 32989926 DOI: 10.1002/psp4.12557] [Reference Citation Analysis]
61 Magalhães TAFM, Souza MO, Gomes SV, Mendes E Silva R, Martins FDS, Freitas RN, Amaral JFD. Açaí (Euterpe oleracea Martius) Promotes Jejunal Tissue Regeneration by Enhancing Antioxidant Response in 5-Fluorouracil-Induced Mucositis. Nutr Cancer 2021;73:523-33. [PMID: 32367766 DOI: 10.1080/01635581.2020.1759659] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
62 Blijlevens NM, van't Land B, Donnelly JP, M'Rabet L, de Pauw BE. Measuring mucosal damage induced by cytotoxic therapy. Support Care Cancer. 2004;12:227-233. [PMID: 14752625 DOI: 10.1007/s00520-003-0572-3] [Cited by in Crossref: 43] [Cited by in F6Publishing: 38] [Article Influence: 2.5] [Reference Citation Analysis]
63 Cardani D, Sardi C, La Ferla B, D'Orazio G, Sommariva M, Marcucci F, Olivero D, Tagliabue E, Koepsell H, Nicotra F, Balsari A, Rumio C. Sodium glucose cotransporter 1 ligand BLF501 as a novel tool for management of gastrointestinal mucositis. Mol Cancer 2014;13:23. [PMID: 24495286 DOI: 10.1186/1476-4598-13-23] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
64 Koetse HA, Klaassen D, van der Molen AR, Elzinga H, Bijsterveld K, Boverhof R, Stellaard F. Combined LDI/SAT test to evaluate intestinal lactose digestion and mucosa permeability. Eur J Clin Invest 2006;36:730-6. [PMID: 16968469 DOI: 10.1111/j.1365-2362.2006.01717.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
65 Gibson RJ, Cummins AG, Bowen JM, Logan RM, Healey T, Keefe DM. Apoptosis occurs early in the basal layer of the oral mucosa following cancer chemotherapy. Asia-Pacific J Clinical Oncology 2006;2:39-49. [DOI: 10.1111/j.1743-7563.2006.00038.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
66 Tung D, Cheung PH, Wilson J, Tudor G, Booth C, Saha S. Differential effects of cyclosporin and etanercept treatment on various pathologic parameters in a murine model of irradiation-induced mucositis. Curr Ther Res Clin Exp 2012;73:150-64. [PMID: 24653517 DOI: 10.1016/j.curtheres.2012.06.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
67 Wardill HR, Bowen JM, Gibson RJ. Biomarkers of small intestinal mucosal damage induced by chemotherapy: an emerging role for the 13C sucrose breath test. J Support Oncol 2013;11:61-7. [PMID: 23158908 DOI: 10.1016/j.suponc.2012.06.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
68 Akpolat M, Oz ZS, Gulle K, Hamamcioglu AC, Bakkal BH, Kececi M. X irradiation induced colonic mucosal injury and the detection of apoptosis through PARP-1/p53 regulatory pathway. Biomed Pharmacother 2020;127:110134. [PMID: 32361637 DOI: 10.1016/j.biopha.2020.110134] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
69 Beutheu Youmba S, Belmonte L, Galas L, Boukhettala N, Bôle-feysot C, Déchelotte P, Coëffier M. Methotrexate Modulates Tight Junctions Through NF-κB, MEK, and JNK Pathways. Journal of Pediatric Gastroenterology & Nutrition 2012;54:463-70. [DOI: 10.1097/mpg.0b013e318247240d] [Cited by in Crossref: 54] [Cited by in F6Publishing: 22] [Article Influence: 6.0] [Reference Citation Analysis]
70 Bou-Hanna C, Jarry A, Lode L, Schmitz I, Schulze-Osthoff K, Kury S, Bezieau S, Mosnier JF, Laboisse CL. Acute cytotoxicity of MIRA-1/NSC19630, a mutant p53-reactivating small molecule, against human normal and cancer cells via a caspase-9-dependent apoptosis. Cancer Lett 2015;359:211-7. [PMID: 25617798 DOI: 10.1016/j.canlet.2015.01.014] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 4.2] [Reference Citation Analysis]
71 Hassanein EHM, Kamel EO, Ali FEM, Ahmed MA. Berberine and/or zinc protect against methotrexate-induced intestinal damage: Role of GSK-3β/NRF2 and JAK1/STAT-3 signaling pathways. Life Sci 2021;281:119754. [PMID: 34174323 DOI: 10.1016/j.lfs.2021.119754] [Reference Citation Analysis]
72 Yoneyama T, Abdul-Hadi K, Brown A, Guan E, Wagoner M, Zhu AZX. A Citrulline-Based Translational Population System Toxicology Model for Gastrointestinal-Related Adverse Events Associated With Anticancer Treatments. CPT Pharmacometrics Syst Pharmacol 2019;8:951-61. [PMID: 31671257 DOI: 10.1002/psp4.12475] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
73 Boukhettala N, Ibrahim A, Claeyssens S, Faure M, Le Pessot F, Vuichoud J, Lavoinne A, Breuillé D, Déchelotte P, Coëffier M. A diet containing whey protein, glutamine, and TGFbeta modulates gut protein metabolism during chemotherapy-induced mucositis in rats. Dig Dis Sci. 2010;55:2172-2181. [PMID: 19911274 DOI: 10.1007/s10620-009-1039-2] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
74 Thorpe D, Sultani M, Stringer A. Irinotecan induces enterocyte cell death and changes to muc2 and muc4 composition during mucositis in a tumour-bearing DA rat model. Cancer Chemother Pharmacol 2019;83:893-904. [PMID: 30815720 DOI: 10.1007/s00280-019-03787-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
75 Munneke JM, Björklund AT, Mjösberg JM, Garming-Legert K, Bernink JH, Blom B, Huisman C, van Oers MH, Spits H, Malmberg KJ, Hazenberg MD. Activated innate lymphoid cells are associated with a reduced susceptibility to graft-versus-host disease. Blood 2014;124:812-21. [PMID: 24855210 DOI: 10.1182/blood-2013-11-536888] [Cited by in Crossref: 139] [Cited by in F6Publishing: 137] [Article Influence: 19.9] [Reference Citation Analysis]
76 Wardill HR, Bowen JM. Chemotherapy-induced mucosal barrier dysfunction: an updated review on the role of intestinal tight junctions. Curr Opin Support Palliat Care 2013;7:155-61. [PMID: 23492816 DOI: 10.1097/SPC.0b013e32835f3e8c] [Cited by in Crossref: 40] [Cited by in F6Publishing: 15] [Article Influence: 5.7] [Reference Citation Analysis]
77 Van Sebille YZ, Gibson RJ, Wardill HR, Carney TJ, Bowen JM. Use of zebrafish to model chemotherapy and targeted therapy gastrointestinal toxicity. Exp Biol Med (Maywood) 2019;244:1178-85. [PMID: 31184924 DOI: 10.1177/1535370219855334] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
78 Gao J, Gao J, Qian L, Wang X, Wu M, Zhang Y, Ye H, Zhu S, Yu Y, Han W. Activation of p38-MAPK by CXCL4/CXCR3 axis contributes to p53-dependent intestinal apoptosis initiated by 5-fluorouracil. Cancer Biol Ther 2014;15:982-91. [PMID: 24800927 DOI: 10.4161/cbt.29114] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 3.1] [Reference Citation Analysis]
79 Sukhotnik I, Shteinberg D, Ben Lulu S, Bashenko Y, Mogilner JG, Ure BM, Shaoul R, Coran AG. Effect of transforming growth factor-alpha on enterocyte apoptosis is correlated with EGF receptor expression along the villus-crypt axis during methotrexate-induced intestinal mucositis in a rat. Apoptosis 2008;13:1344-55. [DOI: 10.1007/s10495-008-0258-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
80 Gibson RJ, Keefe DM, Thompson FM, Clarke JM, Goland GJ, Cummins AG. Effect of interleukin-11 on ameliorating intestinal damage after methotrexate treatment of breast cancer in rats. Dig Dis Sci. 2002;47:2751-2757. [PMID: 12498296 DOI: 10.1023/a:1021061306913] [Cited by in Crossref: 69] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
81 Stringer AM, Gibson RJ, Logan RM, Bowen JM, Yeoh AS, Hamilton J, Keefe DM. Gastrointestinal microflora and mucins may play a critical role in the development of 5-Fluorouracil-induced gastrointestinal mucositis. Exp Biol Med (Maywood) 2009;234:430-41. [PMID: 19176868 DOI: 10.3181/0810-RM-301] [Cited by in Crossref: 132] [Cited by in F6Publishing: 53] [Article Influence: 11.0] [Reference Citation Analysis]
82 Escalante J, Mcquade RM, Stojanovska V, Nurgali K. Impact of chemotherapy on gastrointestinal functions and the enteric nervous system. Maturitas 2017;105:23-9. [DOI: 10.1016/j.maturitas.2017.04.021] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 4.5] [Reference Citation Analysis]
83 Vijayalakshmi B, Sesikeran B, Udaykumar P, Kalyanasundaram S, Raghunath M. Chronic low vitamin intake potentiates cisplatin-induced intestinal epithelial cell apoptosis in WNIN rats. World J Gastroenterol 2006; 12(7): 1078-1085 [PMID: 16534849 DOI: 10.3748/wjg.v12.i7.1078] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
84 Wang H, Bastian SEP, Howarth GS. Newly Developed Synbiotics and the Chemotherapy-Damaged Gut. J Evid Based Complementary Altern Med 2013;18:198-208. [DOI: 10.1177/2156587213477864] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
85 Abalo R, Uranga JA, Pérez-García I, de Andrés R, Girón R, Vera G, López-Pérez AE, Martín-Fontelles MI. May cannabinoids prevent the development of chemotherapy-induced diarrhea and intestinal mucositis? Experimental study in the rat. Neurogastroenterol Motil 2017;29. [PMID: 27686064 DOI: 10.1111/nmo.12952] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
86 Fuereder T, Koni D, Gleiss A, Kundi M, Makristathis A, Zielinski C, Steininger C. Risk factors for Clostridium difficile infection in hemato-oncological patients: A case control study in 144 patients. Sci Rep 2016;6:31498. [PMID: 27510591 DOI: 10.1038/srep31498] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
87 Bertoglio JC, Calderón S, Lesina B, Pilleux L, Morazzoni P, Riva A, Bombardelli E, Ronchi M, Cabri W, Petrangolini G. Effect of SAMITAL® in the treatment of chemotherapy-induced mucositis in adult oncohematological patients. Future Oncol 2013;9:1727-32. [PMID: 24156332 DOI: 10.2217/fon.13.164] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
88 Bowen JM, Gibson RJ, Stringer AM, Chan TW, Prabowo AS, Cummins AG, Keefe DM. Role of p53 in irinotecan-induced intestinal cell death and mucosal damage. Anticancer Drugs. 2007;18:197-210. [PMID: 17159606 DOI: 10.1097/CAD.0b013e328010ef29] [Cited by in Crossref: 16] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
89 Oh N, Lee J, Lee J, Lee K, Kim Y. Mulberry leaf extract fermented with Lactobacillus acidophilus A4 ameliorates 5-fluorouracil-induced intestinal mucositis in rats. Lett Appl Microbiol 2017;64:459-68. [DOI: 10.1111/lam.12741] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
90 Wardill HR, Bowen JM, Gibson RJ. Chemotherapy-induced gut toxicity: are alterations to intestinal tight junctions pivotal? Cancer Chemother Pharmacol 2012;70:627-35. [DOI: 10.1007/s00280-012-1989-5] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
91 Xie JH, Fan ST, Nie SP, Yu Q, Xiong T, Gong D, Xie MY. Lactobacillus plantarum NCU116 attenuates cyclophosphamide-induced intestinal mucosal injury, metabolism and intestinal microbiota disorders in mice. Food Funct 2016;7:1584-92. [PMID: 26906433 DOI: 10.1039/c5fo01516b] [Cited by in Crossref: 26] [Cited by in F6Publishing: 11] [Article Influence: 5.2] [Reference Citation Analysis]
92 Levin G, Shirvan A, Grimberg H, Reshef A, Yogev-Falach M, Cohen A, Ziv I. Novel fluorescence molecular imaging of chemotherapy-induced intestinal apoptosis. J Biomed Opt 2009;14:054019. [PMID: 19895121 DOI: 10.1117/1.3253303] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
93 Wardill HR, Logan RM, Bowen JM, Van Sebille YZA, Gibson RJ. Tight junction defects are seen in the buccal mucosa of patients receiving standard dose chemotherapy for cancer. Support Care Cancer 2016;24:1779-88. [DOI: 10.1007/s00520-015-2964-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
94 Sukhotnik I, Moati D, Shaoul R, Loberman B, Pollak Y, Schwartz B. Quercetin prevents small intestinal damage and enhances intestinal recovery during methotrexate-induced intestinal mucositis of rats. Food Nutr Res 2018;62. [PMID: 30026677 DOI: 10.29219/fnr.v62.1327] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 4.7] [Reference Citation Analysis]
95 Abdel Moneim AE, Guerra-Librero A, Florido J, Shen YQ, Fernández-Gil B, Acuña-Castroviejo D, Escames G. Oral Mucositis: Melatonin Gel an Effective New Treatment. Int J Mol Sci 2017;18:E1003. [PMID: 28481279 DOI: 10.3390/ijms18051003] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 4.5] [Reference Citation Analysis]
96 Chen Y, Zheng H, Zhang J, Wang L, Jin Z, Gao W. Reparative activity of costunolide and dehydrocostus in a mouse model of 5-fluorouracil-induced intestinal mucositis. RSC Adv 2016;6:5249-58. [DOI: 10.1039/c5ra22371g] [Cited by in Crossref: 7] [Article Influence: 1.4] [Reference Citation Analysis]
97 Garin-Laflam MP, Steinbrecher KA, Rudolph JA, Mao J, Cohen MB. Activation of guanylate cyclase C signaling pathway protects intestinal epithelial cells from acute radiation-induced apoptosis. Am J Physiol Gastrointest Liver Physiol. 2009;296:G740-G749. [PMID: 19221018 DOI: 10.1152/ajpgi.90268.2008] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 2.3] [Reference Citation Analysis]
98 Rubenstein EB, Peterson DE, Schubert M, Keefe D, McGuire D, Epstein J, Elting LS, Fox PC, Cooksley C, Sonis ST. Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis. Cancer. 2004;100:2026-2046. [PMID: 15108223 DOI: 10.1002/cncr.20163] [Cited by in Crossref: 505] [Cited by in F6Publishing: 402] [Article Influence: 29.7] [Reference Citation Analysis]
99 Ben-Lulu S, Pollak Y, Mogilner J, Bejar J, G Coran A, Sukhotnik I. Dietary transforming growth factor-beta 2 (TGF-β2) supplementation reduces methotrexate-induced intestinal mucosal injury in a rat. PLoS One 2012;7:e45221. [PMID: 22984629 DOI: 10.1371/journal.pone.0045221] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 2.7] [Reference Citation Analysis]
100 Alamir I, Boukhettala N, Aziz M, Breuillé D, Déchelotte P, Coëffier M. Beneficial effects of cathepsin inhibition to prevent chemotherapy-induced intestinal mucositis. Clin Exp Immunol. 2010;162:298-305. [PMID: 20731673 DOI: 10.1111/j.1365-2249.2010.04220.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]
101 Wang M, Zhang J, Zhao H, Wan D, Jiang Z. Berberine combined with cyclosporine A alleviates acute graft-versus-host disease in murine models. International Immunopharmacology 2020;81:106205. [DOI: 10.1016/j.intimp.2020.106205] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
102 Darwich AS, Burt HJ, Rostami-Hodjegan A. The nested enzyme-within-enterocyte (NEWE) turnover model for predicting dynamic drug and disease effects on the gut wall. Eur J Pharm Sci 2019;131:195-207. [PMID: 30776469 DOI: 10.1016/j.ejps.2019.02.017] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
103 Bajic JE, Johnston IN, Howarth GS, Hutchinson MR. From the Bottom-Up: Chemotherapy and Gut-Brain Axis Dysregulation. Front Behav Neurosci 2018;12:104. [PMID: 29872383 DOI: 10.3389/fnbeh.2018.00104] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 8.7] [Reference Citation Analysis]
104 El-ghazaly MA, El-hazek RM, Khayyal MT. Protective effect of the herbal preparation, STW 5, against intestinal damage induced by gamma radiation in rats. International Journal of Radiation Biology 2015;91:150-6. [DOI: 10.3109/09553002.2014.954059] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
105 Shankaran H, Cronin A, Barnes J, Sharma P, Tolsma J, Jasper P, Mettetal JT. Systems Pharmacology Model of Gastrointestinal Damage Predicts Species Differences and Optimizes Clinical Dosing Schedules. CPT Pharmacometrics Syst Pharmacol 2018;7:26-33. [PMID: 28941225 DOI: 10.1002/psp4.12255] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
106 Teoh F, Pavelka N. How Chemotherapy Increases the Risk of Systemic Candidiasis in Cancer Patients: Current Paradigm and Future Directions. Pathogens 2016;5:E6. [PMID: 26784236 DOI: 10.3390/pathogens5010006] [Cited by in Crossref: 35] [Cited by in F6Publishing: 28] [Article Influence: 7.0] [Reference Citation Analysis]
107 Kovac RL, Ballash G, Fenger J, London C, Warry E. Plasma cytokeratin-18 concentrations as noninvasive biomarker of early gastrointestinal toxicosis in dogs receiving toceranib. J Vet Intern Med 2018;32:2061-8. [PMID: 30353992 DOI: 10.1111/jvim.15326] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
108 Nexoe AB, Pedersen AA, von Huth S, Sorensen GL, Holmskov U, Jiang PP, Detlefsen S, Husby S, Rathe M. No effect of deleted in malignant brain tumors 1 deficiency on chemotherapy induced murine intestinal mucositis. Sci Rep 2021;11:14687. [PMID: 34282203 DOI: 10.1038/s41598-021-94076-w] [Reference Citation Analysis]
109 Thorpe D, Butler R, Sultani M, Vanhoecke B, Stringer A. Irinotecan-Induced Mucositis Is Associated with Goblet Cell Dysregulation and Neural Cell Damage in a Tumour Bearing DA Rat Model. Pathol Oncol Res 2020;26:955-65. [PMID: 30919275 DOI: 10.1007/s12253-019-00644-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
110 Deng W, Balazs L, Wang DA, Van Middlesworth L, Tigyi G, Johnson LR. Lysophosphatidic acid protects and rescues intestinal epithelial cells from radiation- and chemotherapy-induced apoptosis. Gastroenterology 2002;123:206-16. [PMID: 12105849 DOI: 10.1053/gast.2002.34209] [Cited by in Crossref: 91] [Cited by in F6Publishing: 83] [Article Influence: 4.8] [Reference Citation Analysis]
111 Bateman E, Bowen J, Stringer A, Mayo B, Plews E, Wignall A, Greenberg N, Schiffrin E, Keefe D. Investigation of effect of nutritional drink on chemotherapy-induced mucosal injury and tumor growth in an established animal model. Nutrients 2013;5:3948-63. [PMID: 24084053 DOI: 10.3390/nu5103948] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
112 Reginelli A, Sangiovanni A, Vacca G, Belfiore MP, Pignatiello M, Viscardi G, Clemente A, Urraro F, Cappabianca S. Chemotherapy-induced bowel ischemia: diagnostic imaging overview. Abdom Radiol (NY) 2021. [PMID: 33811514 DOI: 10.1007/s00261-021-03024-9] [Reference Citation Analysis]
113 Boukhettala N, Leblond J, Claeyssens S, Faure M, Le Pessot F, Bôle-feysot C, Hassan A, Mettraux C, Vuichoud J, Lavoinne A, Breuillé D, Déchelotte P, Coëffier M. Methotrexate induces intestinal mucositis and alters gut protein metabolism independently of reduced food intake. American Journal of Physiology-Endocrinology and Metabolism 2009;296:E182-90. [DOI: 10.1152/ajpendo.90459.2008] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 3.4] [Reference Citation Analysis]
114 Leblond J, Le Pessot F, Hubert-Buron A, Duclos C, Vuichoud J, Faure M, Breuillé D, Déchelotte P, Coëffier M. Chemotherapy-induced mucositis is associated with changes in proteolytic pathways. Exp Biol Med (Maywood). 2008;233:219-228. [PMID: 18222977 DOI: 10.3181/0702-RM-49] [Cited by in Crossref: 23] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
115 Singh K, Cao H, Miaskowski C, Conley YP, Hammer M, Wright F, Levine JD, Kober KM. Perturbations in Endocytotic and Apoptotic Pathways Are Associated With Chemotherapy-Induced Nausea. Biol Res Nurs 2021;23:238-47. [PMID: 32815385 DOI: 10.1177/1099800420951271] [Reference Citation Analysis]
116 Deng W, Viar MJ, Johnson LR. Polyamine depletion inhibits irradiation-induced apoptosis in intestinal epithelia. Am J Physiol Gastrointest Liver Physiol 2005;289:G599-606. [PMID: 15860639 DOI: 10.1152/ajpgi.00564.2004] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.2] [Reference Citation Analysis]
117 Kato S, Hayashi S, Kitahara Y, Nagasawa K, Aono H, Shibata J, Utsumi D, Amagase K, Kadowaki M. Saireito (TJ-114), a Japanese traditional herbal medicine, reduces 5-fluorouracil-induced intestinal mucositis in mice by inhibiting cytokine-mediated apoptosis in intestinal crypt cells. PLoS One 2015;10:e0116213. [PMID: 25565296 DOI: 10.1371/journal.pone.0116213] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 5.2] [Reference Citation Analysis]
118 Prisciandaro LD, Geier MS, Butler RN, Cummins AG, Howarth GS. Evidence supporting the use of probiotics for the prevention and treatment of chemotherapy-induced intestinal mucositis. Crit Rev Food Sci Nutr. 2011;51:239-247. [PMID: 21390944 DOI: 10.1080/10408390903551747] [Cited by in Crossref: 48] [Cited by in F6Publishing: 42] [Article Influence: 4.8] [Reference Citation Analysis]
119 Rtibi K, Selmi S, Grami D, Amri M, Sebai H, Marzouki L. Contribution of oxidative stress in acute intestinal mucositis induced by 5 fluorouracil (5-FU) and its pro-drug capecitabine in rats. Toxicology Mechanisms and Methods 2018;28:262-7. [DOI: 10.1080/15376516.2017.1402976] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
120 Zhan YS, Tan SW, Mao W, Jiang J, Liu HL, Wu B. Chemotherapy mediates intestinal injury via p53/p53 upregulated modulator of apoptosis (PUMA) signaling pathway: Chemotherapy mediates intestinal injury. Journal of Digestive Diseases 2014;15:425-34. [DOI: 10.1111/1751-2980.12157] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
121 van der Velden WJ, Herbers AH, Netea MG, Blijlevens NM. Mucosal barrier injury, fever and infection in neutropenic patients with cancer: introducing the paradigm febrile mucositis. Br J Haematol. 2014;167:441-452. [PMID: 25196917 DOI: 10.1111/bjh.13113] [Cited by in Crossref: 64] [Cited by in F6Publishing: 54] [Article Influence: 9.1] [Reference Citation Analysis]
122 Yasuda M, Kato S, Yamanaka N, Iimori M, Utsumi D, Kitahara Y, Iwata K, Matsuno K, Amagase K, Yabe-Nishimura C. Potential role of the NADPH oxidase NOX1 in the pathogenesis of 5-fluorouracil-induced intestinal mucositis in mice. Am J Physiol Gastrointest Liver Physiol. 2012;302:G1133-G1142. [PMID: 22403796 DOI: 10.1152/ajpgi.00535.2011] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 3.6] [Reference Citation Analysis]
123 Khan S, Wardill HR, Bowen JM. Role of toll-like receptor 4 (TLR4)-mediated interleukin-6 (IL-6) production in chemotherapy-induced mucositis. Cancer Chemother Pharmacol 2018;82:31-7. [PMID: 29845394 DOI: 10.1007/s00280-018-3605-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
124 Ali J, Khan AU, Shah FA, Ali H, Islam SU, Kim YS, Khan S. Mucoprotective effects of Saikosaponin-A in 5-fluorouracil-induced intestinal mucositis in mice model. Life Sciences 2019;239:116888. [DOI: 10.1016/j.lfs.2019.116888] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 8.5] [Reference Citation Analysis]
125 Yeoh AS, Bowen JM, Gibson RJ, Keefe DM. Nuclear factor kappaB (NFkappaB) and cyclooxygenase-2 (Cox-2) expression in the irradiated colorectum is associated with subsequent histopathological changes. Int J Radiat Oncol Biol Phys. 2005;63:1295-1303. [PMID: 16099597 DOI: 10.1016/j.ijrobp.2005.04.041] [Cited by in Crossref: 68] [Cited by in F6Publishing: 63] [Article Influence: 4.3] [Reference Citation Analysis]
126 Koizumi R, Azuma K, Izawa H, Morimoto M, Ochi K, Tsuka T, Imagawa T, Osaki T, Ito N, Okamoto Y, Saimoto H, Ifuku S. Oral Administration of Surface-Deacetylated Chitin Nanofibers and Chitosan Inhibit 5-Fluorouracil-Induced Intestinal Mucositis in Mice. Int J Mol Sci 2017;18:E279. [PMID: 28134832 DOI: 10.3390/ijms18020279] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
127 Walters JR. New advances in the molecular and cellular biology of the small intestine. Curr Opin Gastroenterol 2002;18:161-7. [PMID: 17033281 DOI: 10.1097/00001574-200203000-00002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
128 Bowen JM, Gibson RJ, Tsykin A, Stringer AM, Logan RM, Keefe DM. Gene expression analysis of multiple gastrointestinal regions reveals activation of common cell regulatory pathways following cytotoxic chemotherapy. Int J Cancer. 2007;121:1847-1856. [PMID: 17594691 DOI: 10.1002/ijc.22895] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 2.4] [Reference Citation Analysis]
129 Xanthinaki A, Nicolatou-Galitis O, Athanassiadou P, Gonidi M, Kouloulias V, Sotiropoulou-Lontou A, Pissakas G, Kyprianou K, Kouvaris J, Patsouris E. Apoptotic and inflammation markers in oral mucositis in head and neck cancer patients receiving radiotherapy: preliminary report. Support Care Cancer 2008;16:1025-33. [PMID: 18197435 DOI: 10.1007/s00520-007-0379-8] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 2.8] [Reference Citation Analysis]
130 Lutgens LC, Blijlevens NM, Deutz NE, Donnelly JP, Lambin P, de Pauw BE. Monitoring myeloablative therapy-induced small bowel toxicity by serum citrulline concentration: a comparison with sugar permeability tests. Cancer. 2005;103:191-199. [PMID: 15573372 DOI: 10.1002/cncr.20733] [Cited by in Crossref: 114] [Cited by in F6Publishing: 94] [Article Influence: 7.1] [Reference Citation Analysis]
131 Szefel J, Kruszewski WJ, Buczek T. Enteral feeding and its impact on the gut immune system and intestinal mucosal barrier. Prz Gastroenterol 2015;10:71-7. [PMID: 26557936 DOI: 10.5114/pg.2015.48997] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
132 Bowen JM, Gibson RJ, Cummins AG, Tyskin A, Keefe DM. Irinotecan changes gene expression in the small intestine of the rat with breast cancer. Cancer Chemother Pharmacol. 2007;59:337-348. [PMID: 16799812 DOI: 10.1007/s00280-006-0275-9] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 2.1] [Reference Citation Analysis]
133 Bateman E, Weaver E, Klein G, Wignall A, Wozniak B, Plews E, Mayo B, White I, Keefe D. Serum-derived bovine immunoglobulin/protein isolate in the alleviation of chemotherapy-induced mucositis. Support Care Cancer 2016;24:377-85. [PMID: 26081596 DOI: 10.1007/s00520-015-2806-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
134 Kamiya A, Machida T, Hirano M, Machida M, Shiga S, Hamaue N, Hirafuji M, Iizuka K. Administration of cyclophosphamide to rats induces pica and potentiates 5-hydroxytryptamine synthesis in the intestine without causing severe intestinal injury. J Pharmacol Sci 2021;147:251-9. [PMID: 34507634 DOI: 10.1016/j.jphs.2021.07.007] [Reference Citation Analysis]
135 Korver SK, Gibson RJ, Bowen JM, Coller JK. Toll-like receptor/interleukin-1 domain innate immune signalling pathway genetic variants are candidate predictors for severe gastrointestinal toxicity risk following 5-fluorouracil-based chemotherapy. Cancer Chemother Pharmacol 2019;83:217-36. [PMID: 30474704 DOI: 10.1007/s00280-018-3729-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
136 Gibson RJ, Bowen JM, Coller JK. What are the predictive factors in the risk and severity of chemotherapy-induced gastrointestinal toxicity? Future Oncol 2015;11:2367-70. [PMID: 26270862 DOI: 10.2217/FON.15.138] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
137 Logan RM, Stringer AM, Bowen JM, Yeoh AS, Gibson RJ, Sonis ST, Keefe DM. The role of pro-inflammatory cytokines in cancer treatment-induced alimentary tract mucositis: pathobiology, animal models and cytotoxic drugs. Cancer Treat Rev. 2007;33:448-460. [PMID: 17507164 DOI: 10.1016/j.ctrv.2007.03.001] [Cited by in Crossref: 179] [Cited by in F6Publishing: 161] [Article Influence: 12.8] [Reference Citation Analysis]
138 Banna GL, Torino F, Marletta F, Santagati M, Salemi R, Cannarozzo E, Falzone L, Ferraù F, Libra M. Lactobacillus rhamnosus GG: An Overview to Explore the Rationale of Its Use in Cancer. Front Pharmacol 2017;8:603. [PMID: 28919861 DOI: 10.3389/fphar.2017.00603] [Cited by in Crossref: 53] [Cited by in F6Publishing: 49] [Article Influence: 13.3] [Reference Citation Analysis]
139 Müller M, Ringer K, Hub F, Kamm N, Worzfeld T, Jacob R. TTL-Expression Modulates Epithelial Morphogenesis. Front Cell Dev Biol 2021;9:635723. [PMID: 33614664 DOI: 10.3389/fcell.2021.635723] [Reference Citation Analysis]
140 Dore MP, Pes GM, Murino A, Quarta Colosso B, Pennazio M. Short article: Small intestinal mucosal injury in patients taking chemotherapeutic agents for solid cancers. Eur J Gastroenterol Hepatol 2017;29:568-71. [PMID: 28350747 DOI: 10.1097/MEG.0000000000000828] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
141 Sangild PT, Shen RL, Pontoppidan P, Rathe M. Animal models of chemotherapy-induced mucositis: translational relevance and challenges. Am J Physiol Gastrointest Liver Physiol 2018;314:G231-46. [PMID: 29074485 DOI: 10.1152/ajpgi.00204.2017] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 5.8] [Reference Citation Analysis]
142 Smith CL, Geier MS, Yazbeck R, Torres DM, Butler RN, Howarth GS. Lactobacillus fermentum BR11 and fructo-oligosaccharide partially reduce jejunal inflammation in a model of intestinal mucositis in rats. Nutr Cancer. 2008;60:757-767. [PMID: 19005975 DOI: 10.1080/01635580802192841] [Cited by in Crossref: 52] [Cited by in F6Publishing: 52] [Article Influence: 4.3] [Reference Citation Analysis]
143 Phillips MA, Narayan R, Padath T, Rubinsky B. Irreversible electroporation on the small intestine. Br J Cancer 2012;106:490-5. [PMID: 22223084 DOI: 10.1038/bjc.2011.582] [Cited by in Crossref: 51] [Cited by in F6Publishing: 39] [Article Influence: 5.7] [Reference Citation Analysis]
144 Bowen JM, Gibson RJ, Keefe DM. Animal Models of Mucositis: Implications for Therapy. The Journal of Supportive Oncology 2011;9:161-8. [DOI: 10.1016/j.suponc.2011.04.009] [Cited by in Crossref: 45] [Cited by in F6Publishing: 39] [Article Influence: 4.5] [Reference Citation Analysis]
145 Al-azri AR, Gibson RJ, Bowen JM, Stringer AM, Keefe DM, Logan RM. Involvement of matrix metalloproteinases (MMP-3 and MMP-9) in the pathogenesis of irinotecan-induced oral mucositis. J Oral Pathol Med 2015;44:459-67. [DOI: 10.1111/jop.12255] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 3.1] [Reference Citation Analysis]
146 Liu T, Wu Y, Wang L, Pang X, Zhao L, Yuan H, Zhang C. A More Robust Gut Microbiota in Calorie-Restricted Mice Is Associated with Attenuated Intestinal Injury Caused by the Chemotherapy Drug Cyclophosphamide. mBio. 2019;10:e02903-18. [PMID: 30862756 DOI: 10.1128/mbio.02903-18] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 10.0] [Reference Citation Analysis]
147 Shen SR, Chen WJ, Chu HF, Wu SH, Wang YR, Shen TL. Amelioration of 5-fluorouracil-induced intestinal mucositis by Streptococcus thermophilus ST4 in a mouse model. PLoS One 2021;16:e0253540. [PMID: 34310611 DOI: 10.1371/journal.pone.0253540] [Reference Citation Analysis]
148 Sukhotnik I, Shehadeh N, Coran AG, Mogilner JG, Karry R, Shamian B, Ure BM, Shamir R. Oral insulin enhances cell proliferation and decreases enterocyte apoptosis during methotrexate-induced mucositis in the rat. J Pediatr Gastroenterol Nutr 2008;47:115-22. [PMID: 18664860 DOI: 10.1097/MPG.0b013e31806008f1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
149 Triantafyllou K, Dervenoulas J, Tsirigotis P, Ladas SD. The nature of small intestinal mucositis: a video-capsule endoscopy study. Support Care Cancer 2008;16:1173-8. [DOI: 10.1007/s00520-008-0404-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
150 Jiang Y, Fan L. The effect of Poria cocos ethanol extract on the intestinal barrier function and intestinal microbiota in mice with breast cancer. J Ethnopharmacol 2021;266:113456. [PMID: 33039631 DOI: 10.1016/j.jep.2020.113456] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
151 Thorpe DW, Stringer AM, Gibson RJ. Chemotherapy-induced mucositis: the role of the gastrointestinal microbiome and toll-like receptors. Exp Biol Med (Maywood). 2013;238:1-6. [PMID: 23479757 DOI: 10.1258/ebm.2012.012260] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.5] [Reference Citation Analysis]
152 Marcussen M, Bødker JS, Christensen HS, Johansen P, Nielsen S, Christiansen I, Bergmann OJ, Bøgsted M, Dybkær K, Vyberg M, Johnsen HE. Molecular Characteristics of High-Dose Melphalan Associated Oral Mucositis in Patients with Multiple Myeloma: A Gene Expression Study on Human Mucosa. PLoS One 2017;12:e0169286. [PMID: 28052121 DOI: 10.1371/journal.pone.0169286] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
153 Chee Chean D, Kuo Zang W, Lim M, Zulkefle N. Health Related Quality of Life (HRQoL) among Breast Cancer Patients Receiving Chemotherapy in Hospital Melaka: Single Centre Experience. Asian Pac J Cancer Prev 2016;17:5121-6. [PMID: 28122444 DOI: 10.22034/APJCP.2016.17.12.5121] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
154 Schauer MC, Holzmann B, Peiper M, Friess H, Knoefel WT, Theisen J. Interleukin-10 and -12 predict chemotherapy-associated toxicity in esophageal adenocarcinoma. J Thorac Oncol 2010;5:1849-54. [PMID: 20881642 DOI: 10.1097/JTO.0b013e3181f19028] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
155 Grant CV, Loman BR, Bailey MT, Pyter LM. Manipulations of the gut microbiome alter chemotherapy-induced inflammation and behavioral side effects in female mice. Brain Behav Immun 2021;95:401-12. [PMID: 33895287 DOI: 10.1016/j.bbi.2021.04.014] [Reference Citation Analysis]
156 Lutgens L, Lambin P. Biomarkers for radiation-induced small bowel epithelial damage: An emerging role for plasma Citrulline. World J Gastroenterol 2007; 13(22): 3033-3042 [PMID: 17589917 DOI: 10.3748/wjg.v13.i22.3033] [Cited by in CrossRef: 71] [Cited by in F6Publishing: 60] [Article Influence: 5.1] [Reference Citation Analysis]
157 Kwon Y. Mechanism-based management for mucositis: option for treating side effects without compromising the efficacy of cancer therapy. Onco Targets Ther 2016;9:2007-16. [PMID: 27103826 DOI: 10.2147/OTT.S96899] [Cited by in Crossref: 39] [Cited by in F6Publishing: 18] [Article Influence: 7.8] [Reference Citation Analysis]
158 Herbers AH, Feuth T, Donnelly JP, Blijlevens NM. Citrulline-based assessment score: first choice for measuring and monitoring intestinal failure after high-dose chemotherapy. Ann Oncol 2010;21:1706-11. [PMID: 20089560 DOI: 10.1093/annonc/mdp596] [Cited by in Crossref: 49] [Cited by in F6Publishing: 34] [Article Influence: 4.5] [Reference Citation Analysis]
159 Blijlevens NM. Cytotoxic treatment-induced gastrointestinal symptoms. Current Opinion in Supportive & Palliative Care 2007;1:16-22. [DOI: 10.1097/spc.0b013e3281108025] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
160 Moyes SM, Killick EM, Morris JF, Kadhim MA, Hill MA, Carr KE. Changes produced by external radiation in parameters influencing intestinal permeability and microparticle uptake in vitro. Int J Radiat Biol 2008;84:467-86. [PMID: 18470746 DOI: 10.1080/09553000802078388] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
161 Keefe DM, Rassias G, O??neil L, Gibson RJ. Severe mucositis: how can nutrition help?: . Current Opinion in Clinical Nutrition and Metabolic Care 2007;10:627-31. [DOI: 10.1097/mco.0b013e3282bf90d6] [Cited by in Crossref: 18] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
162 Fijlstra M, Schierbeek H, Voortman G, Dorst KY, van Goudoever JB, Rings EH, Tissing WJ. Continuous enteral administration can enable normal amino acid absorption in rats with methotrexate-induced gastrointestinal mucositis. J Nutr 2012;142:1983-90. [PMID: 23054309 DOI: 10.3945/jn.112.165209] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
163 Gibson RJ, Coller JK, Wardill HR, Hutchinson MR, Smid S, Bowen JM. Chemotherapy-induced gut toxicity and pain: involvement of TLRs. Support Care Cancer 2016;24:2251-8. [PMID: 26581898 DOI: 10.1007/s00520-015-3020-2] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.7] [Reference Citation Analysis]
164 Bujold K, Hauer-Jensen M, Donini O, Rumage A, Hartman D, Hendrickson HP, Stamatopoulos J, Naraghi H, Pouliot M, Ascah A, Sebastian M, Pugsley MK, Wong K, Authier S. Citrulline as a Biomarker for Gastrointestinal-Acute Radiation Syndrome: Species Differences and Experimental Condition Effects. Radiat Res 2016;186:71-8. [PMID: 27351760 DOI: 10.1667/RR14305.1] [Cited by in Crossref: 35] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
165 Szebeni GJ, Vizler C, Nagy LI, Kitajka K, Puskas LG. Pro-Tumoral Inflammatory Myeloid Cells as Emerging Therapeutic Targets. Int J Mol Sci 2016;17:E1958. [PMID: 27886105 DOI: 10.3390/ijms17111958] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 5.2] [Reference Citation Analysis]
166 Blijlevens NM, Lutgens LC, Schattenberg AV, Donnelly JP. Citrulline: a potentially simple quantitative marker of intestinal epithelial damage following myeloablative therapy. Bone Marrow Transplant. 2004;34:193-196. [PMID: 15170165 DOI: 10.1038/sj.bmt.1704563] [Cited by in Crossref: 86] [Cited by in F6Publishing: 80] [Article Influence: 5.4] [Reference Citation Analysis]
167 Eun H, Hur H, Byun CS, Son SY, Han SU, Cho YK. Effects of Continuing Adjuvant S-1 for 1 Year on the Prognosis of Gastric Cancer Patients: Results from a Prospective Single Center Study. J Gastric Cancer 2015;15:113-20. [PMID: 26161284 DOI: 10.5230/jgc.2015.15.2.113] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
168 Blijlevens NMA, Donnelly JP, Depauw BE. Inflammatory response to mucosal barrier injury after myeloablative therapy in allogeneic stem cell transplant recipients. Bone Marrow Transplant 2005;36:703-7. [DOI: 10.1038/sj.bmt.1705118] [Cited by in Crossref: 58] [Cited by in F6Publishing: 46] [Article Influence: 3.6] [Reference Citation Analysis]
169 Al-Dasooqi N, Gibson RJ, Bowen JM, Keefe DM. Matrix metalloproteinases: key regulators in the pathogenesis of chemotherapy-induced mucositis? Cancer Chemother Pharmacol. 2009;64:1-9. [PMID: 19305997 DOI: 10.1007/s00280-009-0984-y] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 2.5] [Reference Citation Analysis]
170 Gibson RJ, Keefe DM, Thompson FM, Clarke JM, Goland GJ, Cummins AG. Effect of interleukin-11 on ameliorating intestinal damage after methotrexate treatment of breast cancer in rats. Dig Dis Sci. 2002;47:2751-2757. [PMID: 12498296 DOI: 10.1023/A: 1021061306913] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
171 Montassier E, Gastinne T, Vangay P, Al-Ghalith GA, Bruley des Varannes S, Massart S, Moreau P, Potel G, de La Cochetière MF, Batard E, Knights D. Chemotherapy-driven dysbiosis in the intestinal microbiome. Aliment Pharmacol Ther 2015;42:515-28. [PMID: 26147207 DOI: 10.1111/apt.13302] [Cited by in Crossref: 173] [Cited by in F6Publishing: 174] [Article Influence: 28.8] [Reference Citation Analysis]
172 Hasenberg T, Essenbreis M, Herold A, Post S, Shang E. Retracted: Early supplementation of parenteral nutrition is capable of improving quality of life, chemotherapy-related toxicity and body composition in patients with advanced colorectal carcinoma undergoing palliative treatment: results from a prospective: Parenteral nutrition supplementation. Colorectal Disease 2010;12:e190-9. [DOI: 10.1111/j.1463-1318.2009.02111.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
173 Bowen JM, Gibson RJ, Cummins AG, Keefe DMK. Intestinal mucositis: the role of the Bcl-2 family, p53 and caspases in chemotherapy-induced damage. Support Care Cancer 2006;14:713-31. [DOI: 10.1007/s00520-005-0004-7] [Cited by in Crossref: 83] [Cited by in F6Publishing: 67] [Article Influence: 5.5] [Reference Citation Analysis]
174 Van Sebille YZ, Gibson RJ, Wardill HR, Bowen JM. ErbB small molecule tyrosine kinase inhibitor (TKI) induced diarrhoea: Chloride secretion as a mechanistic hypothesis. Cancer Treat Rev 2015;41:646-52. [PMID: 26073491 DOI: 10.1016/j.ctrv.2015.05.011] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 5.3] [Reference Citation Analysis]
175 Verburg M, Renes IB, Nispen DJV, Ferdinandusse S, Jorritsma M, Büller HA, Einerhand AW, Dekker J. Specific Responses in Rat Small Intestinal Epithelial mRNA Expression and Protein Levels During Chemotherapeutic Damage and Regeneration. J Histochem Cytochem 2002;50:1525-36. [DOI: 10.1177/002215540205001113] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 6.2] [Reference Citation Analysis]
176 Zuo T, Li X, Chang Y, Duan G, Yu L, Zheng R, Xue C, Tang Q. Dietary fucoidan of Acaudina molpadioides and its enzymatically degraded fragments could prevent intestinal mucositis induced by chemotherapy in mice. Food Funct 2015;6:415-22. [DOI: 10.1039/c4fo00567h] [Cited by in Crossref: 47] [Cited by in F6Publishing: 12] [Article Influence: 7.8] [Reference Citation Analysis]
177 Wang X, Zhu S, Qian L, Gao J, Wu M, Gao J, Zhang Y, Chan GL, Yu Y, Han W. IL-1Ra selectively protects intestinal crypt epithelial cells, but not tumor cells, from chemotoxicity via p53-mediated upregulation of p21WAF1 and p27KIP1. Pharmacological Research 2014;82:21-33. [DOI: 10.1016/j.phrs.2014.03.007] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
178 Al-Dasooqi N, Sonis ST, Bowen JM, Bateman E, Blijlevens N, Gibson RJ, Logan RM, Nair RG, Stringer AM, Yazbeck R, Elad S, Lalla RV; Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO). Emerging evidence on the pathobiology of mucositis. Support Care Cancer 2013;21:3233-41. [PMID: 23842598 DOI: 10.1007/s00520-013-1900-x] [Cited by in Crossref: 77] [Cited by in F6Publishing: 61] [Article Influence: 9.6] [Reference Citation Analysis]
179 Kato S, Hamouda N, Kano Y, Oikawa Y, Tanaka Y, Matsumoto K, Amagase K, Shimakawa M. Probiotic Bifidobacterium bifidum G9-1 attenuates 5-fluorouracil-induced intestinal mucositis in mice via suppression of dysbiosis-related secondary inflammatory responses. Clin Exp Pharmacol Physiol 2017;44:1017-25. [DOI: 10.1111/1440-1681.12792] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 6.8] [Reference Citation Analysis]
180 Wang Y, George SP, Srinivasan K, Patnaik S, Khurana S. Actin reorganization as the molecular basis for the regulation of apoptosis in gastrointestinal epithelial cells. Cell Death Differ 2012;19:1514-24. [PMID: 22421965 DOI: 10.1038/cdd.2012.28] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
181 Koppelmann T, Pollak Y, Ben-Shahar Y, Gorelik G, Sukhotnik I. The Mechanisms of the Anti-Inflammatory and Anti-Apoptotic Effects of Omega-3 Polyunsaturated Fatty Acids during Methotrexate-Induced Intestinal Damage in Cell Line and in a Rat Model. Nutrients 2021;13:888. [PMID: 33801889 DOI: 10.3390/nu13030888] [Reference Citation Analysis]
182 Thorpe D. The role of mucins in mucositis. Curr Opin Support Palliat Care 2019;13:114-8. [PMID: 30893104 DOI: 10.1097/SPC.0000000000000423] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
183 Wang H, Bastian SE, Cheah KY, Lawrence A, Howarth GS. Escherichia coli Nissle 1917-derived factors reduce cell death and late apoptosis and increase transepithelial electrical resistance in a model of 5-fluorouracil-induced intestinal epithelial cell damage. Cancer Biol Ther 2014;15:560-9. [PMID: 24556751 DOI: 10.4161/cbt.28159] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
184 Kim SH, Chun HJ, Choi HS, Kim ES, Keum B, Seo YS, Jeen YT, Lee HS, Um SH, Kim CD. Ursodeoxycholic acid attenuates 5-fluorouracil-induced mucositis in a rat model. Oncol Lett 2018;16:2585-90. [PMID: 30008943 DOI: 10.3892/ol.2018.8893] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
185 Tung D, Cheung PH, Tudor G, Booth C, Saha S. In vivo effects of immunomodulators in a murine model of Fluorouracil-induced mucositis. Curr Ther Res Clin Exp 2011;72:262-72. [PMID: 24648594 DOI: 10.1016/j.curtheres.2011.11.003] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
186 Wardill HR, Bowen JM, Al-Dasooqi N, Sultani M, Bateman E, Stansborough R, Shirren J, Gibson RJ. Irinotecan disrupts tight junction proteins within the gut : implications for chemotherapy-induced gut toxicity. Cancer Biol Ther 2014;15:236-44. [PMID: 24316664 DOI: 10.4161/cbt.27222] [Cited by in Crossref: 48] [Cited by in F6Publishing: 38] [Article Influence: 6.0] [Reference Citation Analysis]
187 Logan RM, Gibson RJ, Sonis ST, Keefe DM. Nuclear factor-kappaB (NF-kappaB) and cyclooxygenase-2 (COX-2) expression in the oral mucosa following cancer chemotherapy. Oral Oncol. 2007;43:395-401. [PMID: 16979925 DOI: 10.1016/j.oraloncology.2006.04.011] [Cited by in Crossref: 111] [Cited by in F6Publishing: 95] [Article Influence: 7.4] [Reference Citation Analysis]
188 Carneiro-Filho BA, Oriá RB, Wood Rea K, Brito GA, Fujii J, Obrig T, Lima AA, Guerrant RL. Alanyl-glutamine hastens morphologic recovery from 5-fluorouracil-induced mucositis in mice. Nutrition. 2004;20:934-941. [PMID: 15474885 DOI: 10.1016/j.nut.2004.06.016] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 2.2] [Reference Citation Analysis]
189 Flórez AB, Sierra M, Ruas-Madiedo P, Mayo B. Susceptibility of lactic acid bacteria, bifidobacteria and other bacteria of intestinal origin to chemotherapeutic agents. Int J Antimicrob Agents 2016;48:547-50. [PMID: 27575730 DOI: 10.1016/j.ijantimicag.2016.07.011] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]
190 McQuade RM, Stojanovska V, Abalo R, Bornstein JC, Nurgali K. Chemotherapy-Induced Constipation and Diarrhea: Pathophysiology, Current and Emerging Treatments. Front Pharmacol 2016;7:414. [PMID: 27857691 DOI: 10.3389/fphar.2016.00414] [Cited by in Crossref: 68] [Cited by in F6Publishing: 60] [Article Influence: 13.6] [Reference Citation Analysis]
191 Pereira VB, Melo AT, Assis-Júnior EM, Wong DV, Brito GA, Almeida PR, Ribeiro RA, Lima-Júnior RC. A new animal model of intestinal mucositis induced by the combination of irinotecan and 5-fluorouracil in mice. Cancer Chemother Pharmacol 2016;77:323-32. [PMID: 26666645 DOI: 10.1007/s00280-015-2938-x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
192 de Koning BA, Philipsen-geerling B, Hoijer M, Hählen K, Büller HA, Pieters R. Protection against chemotherapy induced mucositis by TGF-β2 in childhood cancer patients: Results from a randomized cross-over study. Pediatr Blood Cancer 2007;48:532-9. [DOI: 10.1002/pbc.20910] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
193 Di GH, Jiang S, Li FQ, Sun JZ, Wu CT, Hu X, Duan HF. Human umbilical cord mesenchymal stromal cells mitigate chemotherapy-associated tissue injury in a pre-clinical mouse model. Cytotherapy 2012;14:412-22. [PMID: 22242830 DOI: 10.3109/14653249.2011.646044] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.2] [Reference Citation Analysis]
194 Al-Dasooqi N, Sonis ST, Bowen JM, Bateman E, Blijlevens N, Gibson RJ, Logan RM, Nair RG, Stringer AM, Yazbeck R, Elad S, Lalla RV; Mucositis Study Group of Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO). Emerging evidence on the pathobiology of mucositis. Support Care Cancer 2013;21:2075-83. [PMID: 23604521 DOI: 10.1007/s00520-013-1810-y] [Cited by in Crossref: 79] [Cited by in F6Publishing: 68] [Article Influence: 9.9] [Reference Citation Analysis]
195 Beutheu S, Ghouzali I, Galas L, Déchelotte P, Coëffier M. Glutamine and arginine improve permeability and tight junction protein expression in methotrexate-treated Caco-2 cells. Clinical Nutrition 2013;32:863-9. [DOI: 10.1016/j.clnu.2013.01.014] [Cited by in Crossref: 55] [Cited by in F6Publishing: 49] [Article Influence: 6.9] [Reference Citation Analysis]
196 Ypsilantis P, Tentes I, Assimakopoulos SF, Kortsaris A, Scopa CD, Simopoulos C. Mesna ameliorates intestinal mucosa damage after ifosfamide administration in the rabbit at a dose-Related manner. Journal of Surgical Research 2004;121:84-91. [DOI: 10.1016/j.jss.2004.03.003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
197 Shen RL, Pontoppidan PE, Rathe M, Jiang P, Hansen CF, Buddington RK, Heegaard PM, Müller K, Sangild PT. Milk diets influence doxorubicin-induced intestinal toxicity in piglets. Am J Physiol Gastrointest Liver Physiol 2016;311:G324-33. [PMID: 27445347 DOI: 10.1152/ajpgi.00373.2015] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
198 Quatrini L, Tumino N, Moretta F, Besi F, Vacca P, Moretta L. Helper Innate Lymphoid Cells in Allogenic Hematopoietic Stem Cell Transplantation and Graft Versus Host Disease. Front Immunol 2020;11:582098. [PMID: 33101308 DOI: 10.3389/fimmu.2020.582098] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
199 Keefe DM, Sonis ST, Bowen JM. Emerging drugs for chemotherapy-induced mucositis. Expert Opin Emerg Drugs. 2008;13:511-522. [PMID: 18764726 DOI: 10.1517/14728214.13.3.511] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 2.6] [Reference Citation Analysis]
200 Van Sebille YZA, Gibson RJ, Wardill HR, Secombe KR, Ball IA, Keefe DMK, Finnie JW, Bowen JM. Dacomitinib-induced diarrhoea is associated with altered gastrointestinal permeability and disruption in ileal histology in rats. Int J Cancer 2017;140:2820-9. [PMID: 28316082 DOI: 10.1002/ijc.30699] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
201 Jin S. Role of p53 in Anticancer Drug Treatment- and Radiation-Induced Injury in Normal Small Intestine. Cancer Biol Med 2012;9:1-8. [PMID: 23691447 DOI: 10.3969/j.issn.2095-3941.2012.01.001] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
202 Quaresma M, Damasceno S, Monteiro C, Lima F, Mendes T, Lima M, Justino P, Barbosa A, Souza M, Souza E, Soares P. Probiotic mixture containing Lactobacillus spp. and Bifidobacterium spp. attenuates 5-fluorouracil-induced intestinal mucositis in mice. Nutr Cancer 2020;72:1355-65. [PMID: 31608714 DOI: 10.1080/01635581.2019.1675719] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
203 O’brien SN, Blijlevens NM, Mahfouz TH, Anaissie EJ. Infections in Patients with Hematological Cancer: Recent Developments. Hematology 2003;2003:438-72. [DOI: 10.1182/asheducation-2003.1.438] [Cited by in Crossref: 59] [Cited by in F6Publishing: 54] [Article Influence: 3.3] [Reference Citation Analysis]
204 Blijlevens NM, Donnelly JP, de Pauw BE. Prospective evaluation of gut mucosal barrier injury following various myeloablative regimens for haematopoietic stem cell transplant. Bone Marrow Transplant 2005;35:707-11. [PMID: 15785771 DOI: 10.1038/sj.bmt.1704863] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 2.8] [Reference Citation Analysis]
205 Singh A, Verma AK, Das P, Prakash S, Pramanik R, Nayak B, Datta Gupta S, Sreenivas V, Kumar L, Ahuja V, Makharia GK. Non‐immunological biomarkers for assessment of villous abnormalities in patients with celiac disease. Journal of Gastroenterology and Hepatology 2019;35:438-45. [DOI: 10.1111/jgh.14852] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
206 Rudolph JA, Poccia JL, Cohen MB. Cyclic AMP activation of the extracellular signal-regulated kinases 1 and 2: implications for intestinal cell survival through the transient inhibition of apoptosis. J Biol Chem 2004;279:14828-34. [PMID: 14744867 DOI: 10.1074/jbc.M310289200] [Cited by in Crossref: 19] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
207 Gibson RJ, Bowen JM, Inglis MR, Cummins AG, Keefe DM. Irinotecan causes severe small intestinal damage, as well as colonic damage, in the rat with implanted breast cancer. J Gastroenterol Hepatol. 2003;18:1095-1100. [PMID: 12911669 DOI: 10.1046/j.1440-1746.2003.03136.x] [Cited by in Crossref: 119] [Cited by in F6Publishing: 112] [Article Influence: 7.0] [Reference Citation Analysis]
208 de Ávila PHM, de Ávila RI, Dos Santos Filho EX, Cunha Bastos CC, Batista AC, Mendonça EF, Serpa RC, Marreto RN, da Cruz AF, Lima EM, Valadares MC. Mucoadhesive formulation of Bidens pilosa L. (Asteraceae) reduces intestinal injury from 5-fluorouracil-induced mucositis in mice. Toxicol Rep 2015;2:563-73. [PMID: 28962391 DOI: 10.1016/j.toxrep.2015.03.003] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 3.2] [Reference Citation Analysis]
209 van der Velden WJ, Blijlevens NM, Donnelly JP. The potential role of lactoferrin and derivatives in the management of infectious and inflammatory complications of hematology patients receiving a hematopoietic stem cell transplantation. Transpl Infect Dis 2008;10:80-9. [PMID: 17605731 DOI: 10.1111/j.1399-3062.2007.00260.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
210 Chang Y, Yu M, Wu K, Hsu M, Chiou Y, Wu H, Peng C, Chao Y. Effectiveness of Parenteral Glutamine on Methotrexate-induced Oral Mucositis in Children with Acute Lymphoblastic Leukemia. Nutrition and Cancer 2017;69:746-51. [DOI: 10.1080/01635581.2017.1324995] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
211 Blijlevens NMA, Donnelly JP, De Pauw BE. Impaired gut function as risk factor for invasive candidiasis in neutropenic patients: Annotation. British Journal of Haematology 2002;117:259-64. [DOI: 10.1046/j.1365-2141.2002.03394.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 1.6] [Reference Citation Analysis]
212 Wu ZQ, Han XD, Wang Y, Yuan KL, Jin ZM, Di JZ, Yan J, Pan Y, Zhang P, Huang XY. Interleukin-1 receptor antagonist reduced apoptosis and attenuated intestinal mucositis in a 5-fluorouracil chemotherapy model in mice. Cancer Chemother Pharmacol. 2011;68:87-96. [PMID: 20844880 DOI: 10.1007/s00280-010-1451-5] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 3.3] [Reference Citation Analysis]
213 Maiti S, Chen G. Methotrexate is a novel inducer of rat liver and intestinal sulfotransferases. Arch Biochem Biophys 2003;418:161-8. [PMID: 14522587 DOI: 10.1016/j.abb.2003.08.019] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 1.3] [Reference Citation Analysis]
214 Gibson RJ, Bowen JM, Keefe DM. Palifermin reduces diarrhea and increases survival following irinotecan treatment in tumor-bearing DA rats. Int J Cancer 2005;116:464-70. [PMID: 15800945 DOI: 10.1002/ijc.21082] [Cited by in Crossref: 54] [Cited by in F6Publishing: 51] [Article Influence: 3.4] [Reference Citation Analysis]
215 Makani V, Zhang B, Han H, Yao Y, Lassalas P, Lou K, Paterson I, Lee VM, Trojanowski JQ, Ballatore C, Smith AB 3rd, Brunden KR. Evaluation of the brain-penetrant microtubule-stabilizing agent, dictyostatin, in the PS19 tau transgenic mouse model of tauopathy. Acta Neuropathol Commun 2016;4:106. [PMID: 27687527 DOI: 10.1186/s40478-016-0378-4] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 6.6] [Reference Citation Analysis]
216 Gao C, Wang AY. Significance of increased apoptosis and Bax expression in human small intestinal adenocarcinoma. J Histochem Cytochem. 2009;57:1139-1148. [PMID: 19729672 DOI: 10.1369/jhc.2009.954446] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 2.5] [Reference Citation Analysis]
217 Hamouda N, Sano T, Oikawa Y, Ozaki T, Shimakawa M, Matsumoto K, Amagase K, Higuchi K, Kato S. Apoptosis, Dysbiosis and Expression of Inflammatory Cytokines are Sequential Events in the Development of 5-Fluorouracil-Induced Intestinal Mucositis in Mice. Basic Clin Pharmacol Toxicol 2017;121:159-68. [PMID: 28374966 DOI: 10.1111/bcpt.12793] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 8.5] [Reference Citation Analysis]
218 Pan DC, Krishnan V, Salinas AK, Kim J, Sun T, Ravid S, Peng K, Wu D, Nurunnabi M, Nelson JA, Niziolek Z, Guo J, Mitragotri S. Hyaluronic acid-doxorubicin nanoparticles for targeted treatment of colorectal cancer. Bioeng Transl Med 2021;6:e10166. [PMID: 33532580 DOI: 10.1002/btm2.10166] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
219 Chang CW, Liu CY, Lee HC, Huang YH, Li LH, Chiau JC, Wang TE, Chu CH, Shih SC, Tsai TH, Chen YJ. Lactobacillus casei Variety rhamnosus Probiotic Preventively Attenuates 5-Fluorouracil/Oxaliplatin-Induced Intestinal Injury in a Syngeneic Colorectal Cancer Model. Front Microbiol 2018;9:983. [PMID: 29867884 DOI: 10.3389/fmicb.2018.00983] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 14.3] [Reference Citation Analysis]
220 Whittaker AL, Zhu Y, Howarth GS, Loung CS, Bastian SEP, Wirthensohn MG. Effects of commercially produced almond by-products on chemotherapy-induced mucositis in rats. World J Gastrointest Pathophysiol 2017; 8(4): 176-187 [PMID: 29184703 DOI: 10.4291/wjgp.v8.i4.176] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
221 McQuade RM, Stojanovska V, Stavely R, Timpani C, Petersen AC, Abalo R, Bornstein JC, Rybalka E, Nurgali K. Oxaliplatin-induced enteric neuronal loss and intestinal dysfunction is prevented by co-treatment with BGP-15. Br J Pharmacol 2018;175:656-77. [PMID: 29194564 DOI: 10.1111/bph.14114] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
222 Gibson RJ, Keefe DM. Cancer chemotherapy-induced diarrhoea and constipation: mechanisms of damage and prevention strategies. Support Care Cancer. 2006;14:890-900. [PMID: 16604351 DOI: 10.1007/s00520-006-0040-y] [Cited by in Crossref: 131] [Cited by in F6Publishing: 113] [Article Influence: 8.7] [Reference Citation Analysis]
223 Deng W, Wang D, Gosmanova E, Johnson LR, Tigyi G. LPA protects intestinal epithelial cells from apoptosis by inhibiting the mitochondrial pathway. American Journal of Physiology-Gastrointestinal and Liver Physiology 2003;284:G821-9. [DOI: 10.1152/ajpgi.00406.2002] [Cited by in Crossref: 55] [Cited by in F6Publishing: 54] [Article Influence: 3.1] [Reference Citation Analysis]
224 Gibson RJ, Bowen JM. Biomarkers of regimen-related mucosal injury. Cancer Treat Rev 2011;37:487-93. [PMID: 21689887 DOI: 10.1016/j.ctrv.2011.05.007] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 2.9] [Reference Citation Analysis]
225 Borner T, Shaulson ED, Ghidewon MY, Barnett AB, Horn CC, Doyle RP, Grill HJ, Hayes MR, De Jonghe BC. GDF15 Induces Anorexia through Nausea and Emesis. Cell Metab 2020;31:351-362.e5. [PMID: 31928886 DOI: 10.1016/j.cmet.2019.12.004] [Cited by in Crossref: 38] [Cited by in F6Publishing: 33] [Article Influence: 38.0] [Reference Citation Analysis]
226 Peterson DE, Keefe DM, Hutchins RD, Schubert MM. Alimentary tract mucositis in cancer patients: impact of terminology and assessment on research and clinical practice. Support Care Cancer 2006;14:499-504. [DOI: 10.1007/s00520-006-0057-2] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 2.1] [Reference Citation Analysis]
227 Billeschou A, Hunt JE, Ghimire A, Holst JJ, Kissow H. Intestinal Adaptation upon Chemotherapy-Induced Intestinal Injury in Mice Depends on GLP-2 Receptor Activation. Biomedicines 2021;9:46. [PMID: 33430185 DOI: 10.3390/biomedicines9010046] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
228 Zhang S, Liu Y, Xiang D, Yang J, Liu D, Ren X, Zhang C. Assessment of dose-response relationship of 5-fluorouracil to murine intestinal injury. Biomed Pharmacother 2018;106:910-6. [PMID: 30119262 DOI: 10.1016/j.biopha.2018.07.029] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
229 Wang H, Brook CL, Whittaker AL, Lawrence A, Yazbeck R, Howarth GS. Effects of Streptococcus thermophilus TH-4 in a rat model of doxorubicin-induced mucositis. Scand J Gastroenterol. 2013;48:959-968. [PMID: 23865592 DOI: 10.3109/00365521.2013.812142] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
230 Keefe DM, Gibson RJ, Hauer-Jensen M. Gastrointestinal mucositis. Semin Oncol Nurs. 2004;20:38-47. [PMID: 15038516 DOI: 10.1053/j.soncn.2003.10.007] [Cited by in Crossref: 60] [Cited by in F6Publishing: 57] [Article Influence: 3.5] [Reference Citation Analysis]
231 Bech AS, Nexoe AB, Dubik M, Moeller JB, Soerensen GL, Holmskov U, Madsen GI, Husby S, Rathe M. Peptidoglycan Recognition Peptide 2 Aggravates Weight Loss in a Murine Model of Chemotherapy-Induced Gastrointestinal Toxicity. Front Oncol 2021;11:635005. [PMID: 33833993 DOI: 10.3389/fonc.2021.635005] [Reference Citation Analysis]
232 Luo X, Liang X, Li J, Shi J, Zhang W, Chai W, Wu J, Guo S, Fang G, Zhou X, Zhang J, Xu K, Zeng J, Niu L. The Effects of Irreversible Electroporation on the Colon in a Porcine Model. PLoS One 2016;11:e0167275. [PMID: 27907057 DOI: 10.1371/journal.pone.0167275] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
233 Bodiga VL, Bodiga S, Surampudi S, Boindala S, Putcha U, Nagalla B, Subramaniam K, Manchala R. Effect of vitamin supplementation on cisplatin-induced intestinal epithelial cell apoptosis in Wistar/NIN rats. Nutrition 2012;28:572-80. [PMID: 22189195 DOI: 10.1016/j.nut.2011.09.007] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
234 Duncan M, Grant G. Oral and intestinal mucositis - causes and possible treatments. Aliment Pharmacol Ther. 2003;18:853-874. [PMID: 14616150 DOI: 10.1046/j.1365-2036.2003.01784.x] [Cited by in Crossref: 140] [Cited by in F6Publishing: 132] [Article Influence: 8.2] [Reference Citation Analysis]
235 Matsuu-matsuyama M, Shichijo K, Okaichi K, Ishii K, Wen CY, Fukuda E, Nakayama T, Nakashima M, Okumura Y, Sekine I. Sucralfate Protects Intestinal Epithelial Cells from Radiation-Induced Apoptosis in Rats. JRR 2006;47:1-8. [DOI: 10.1269/jrr.47.1] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]